SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-017007
Filing Date
2021-12-23
Accepted
2021-12-23 07:11:35
Documents
96
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-K otlk-20210930x10k.htm   iXBRL 10-K 2493273
2 EX-21.1 otlk-20210930xex21d1.htm EX-21.1 4800
3 EX-23.1 otlk-20210930xex23d1.htm EX-23.1 3844
4 EX-31.1 otlk-20210930xex31d1.htm EX-31.1 13566
5 EX-31.2 otlk-20210930xex31d2.htm EX-31.2 13984
6 EX-32.1 otlk-20210930xex32d1.htm EX-32.1 12777
7 GRAPHIC otlk-20210930x10k006.jpg GRAPHIC 16712
8 GRAPHIC otlk-20210930x10k007.jpg GRAPHIC 25851
9 GRAPHIC otlk-20210930x10k008.jpg GRAPHIC 26893
  Complete submission text file 0001558370-21-017007.txt   10630932

Data Files

Seq Description Document Type Size
10 EX-101.SCH otlk-20210930.xsd EX-101.SCH 66436
11 EX-101.CAL otlk-20210930_cal.xml EX-101.CAL 68545
12 EX-101.DEF otlk-20210930_def.xml EX-101.DEF 345878
13 EX-101.LAB otlk-20210930_lab.xml EX-101.LAB 511020
14 EX-101.PRE otlk-20210930_pre.xml EX-101.PRE 535269
90 EXTRACTED XBRL INSTANCE DOCUMENT otlk-20210930x10k_htm.xml XML 1857467
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37759 | Film No.: 211514774
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences